Product NDC: | 0078-0109 |
Proprietary Name: | Sandimmune |
Non Proprietary Name: | cyclosporine |
Active Ingredient(s): | 50 mg/mL & nbsp; cyclosporine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0109 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050573 |
Marketing Category: | NDA |
Start Marketing Date: | 19831114 |
Package NDC: | 0078-0109-01 |
Package Description: | 10 AMPULE in 1 BOX (0078-0109-01) > 5 mL in 1 AMPULE (0078-0109-61) |
NDC Code | 0078-0109-01 |
Proprietary Name | Sandimmune |
Package Description | 10 AMPULE in 1 BOX (0078-0109-01) > 5 mL in 1 AMPULE (0078-0109-61) |
Product NDC | 0078-0109 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cyclosporine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19831114 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | CYCLOSPORINE |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |